3DV+TPS Software Outlines the Radiotherapy of Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma Clinical Trial

Official title:

3DV+TPS Software Outlines the Outline of Radiotherapy for Nasopharyngeal Carcinoma Center Comparison Study Clinical Research

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03810274
• Other study ID #: XQonc-012
• Status: Completed
• Start date: February 1, 2012
• Est. completion date: January 15, 2019

Study information

• Verified date: January 2019
• Source: Xinqiao Hospital of Chongqing
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Comparing the accuracy and speed of 3DV+TPS software with imported TPS and domestic TPS to outline the contours of crisis organs, it is proved that 3DV+TPS has superiority compared with domestic TPS, and it has non-inferiority compared with imported TPS, indicating that the software can improve contour sketching accuracy. And speed, reduce the burden on doctors, improve medical efficiency.

Description:

Comparing the accuracy and speed difference between 3DV+TPS software and imported TPS and domestic TPS to outline the contours of crisis organs, the selected organs are: bilateral eyeballs, bilateral crystals, bilateral optic nerves, bilateral parotid glands, oral cavity, spinal cord, brainstem, The brain has a total of 12 organs; verify that 3DV+TPS is superior to domestic TPS, and has non-inferiority compared with imported TPS, Ming software can improve the accuracy and speed of contour sketching, reduce the burden on doctors, and improve medical efficiency.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 300
• Est. completion date: January 15, 2019
• Est. primary completion date: December 31, 2018
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 70 Years

Eligibility

Inclusion Criteria:

1. It is diagnosed as nasopharyngeal carcinoma by histopathological examination, and there is no tumor invasion in the organs that need to be assessed;

2. Age 18-70 years old;

3. There is nasopharynx localization enhanced CT, nasopharynx enhanced MRI.

Exclusion Criteria:

1. Patient information is incomplete; no age, gender, MRI, height, radiotherapy location CT;

2. The organs at risk that need to be assessed are invaded by the tumor;

3. Any reason cannot be combined with the research or the researcher believes that it is not suitable for inclusion in this test.

Related Conditions & MeSH terms

• Carcinoma
• Nasopharyngeal Carcinoma
• Nasopharyngeal Neoplasms
• Radiotherapy

Intervention

Device:
• 3DV+TPS;VARIAN TPS;FonicsPlan

Locations

Country	Name	City	State
China	Xinqiao Hospital of Chongqing	Chongqing

Sponsors (1)

Lead Sponsor	Collaborator
Xinqiao Hospital of Chongqing

Country where clinical trial is conducted

China, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Sketching accuracy	Define ?V as a percentage of the total volume of the gold standard;	one year
Primary	Sketch speed	Use the stopwatch to record the total time used to draw down 12 organs, to start sketching as the starting point of the time, and to finish the saving of the data.	one year